Home ›
DE ›
NEWARK ›
MEDICAL ONCOLOGY HEMATOLOGY CONSULTANTS PA
MEDICAL ONCOLOGY HEMATOLOGY CONSULTANTS PA
NPI: 1235199316
· NEWARK, DE 19713
· 207RH0003X
$7.67M
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
5,376 |
$131K |
| 2019 |
4,622 |
$125K |
| 2020 |
8,253 |
$535K |
| 2021 |
6,243 |
$1.26M |
| 2022 |
8,520 |
$2.88M |
| 2023 |
10,434 |
$2.16M |
| 2024 |
7,397 |
$584K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9271 |
Inj pembrolizumab |
692 |
505 |
$5.54M |
| 96413 |
|
8,039 |
3,895 |
$540K |
| 99214 |
|
7,549 |
5,717 |
$384K |
| J1454 |
Inj fosnetupitant, palonoset |
886 |
494 |
$248K |
| 99213 |
|
6,475 |
5,134 |
$231K |
| J0897 |
Denosumab injection |
96 |
74 |
$113K |
| 99215 |
Prolong outpt/office vis |
1,698 |
1,262 |
$112K |
| J1437 |
Inj. fe derisomaltose 10 mg |
105 |
73 |
$97K |
| 96375 |
|
5,892 |
2,586 |
$91K |
| 96417 |
|
2,020 |
1,062 |
$77K |
| 96365 |
|
1,636 |
990 |
$49K |
| 96367 |
|
2,576 |
1,343 |
$42K |
| J1453 |
Fosaprepitant injection |
436 |
200 |
$34K |
| J2469 |
Palonosetron hcl |
1,393 |
560 |
$23K |
| 96415 |
|
1,147 |
586 |
$19K |
| 99204 |
|
232 |
180 |
$17K |
| 96372 |
|
1,526 |
956 |
$14K |
| 99205 |
Prolong outpt/office vis |
72 |
66 |
$9K |
| 99232 |
|
218 |
57 |
$7K |
| 99233 |
Prolong inpt eval add15 m |
131 |
29 |
$5K |
| 99223 |
Prolong inpt eval add15 m |
47 |
38 |
$5K |
| J1100 |
Dexamethasone sodium phos |
5,381 |
2,349 |
$4K |
| 96411 |
|
89 |
52 |
$3K |
| 96401 |
|
76 |
39 |
$3K |
| 99203 |
|
31 |
26 |
$2K |
| 99222 |
|
22 |
16 |
$2K |
| J9045 |
Carboplatin injection |
117 |
64 |
$1K |
| J1200 |
Diphenhydramine hcl injectio |
1,798 |
882 |
$748.37 |
| 96366 |
|
54 |
25 |
$598.31 |
| 96361 |
|
52 |
28 |
$593.03 |
| J7030 |
Normal saline solution infus |
216 |
106 |
$410.49 |
| G2211 |
Complex e/m visit add on |
43 |
38 |
$155.03 |
| 36591 |
|
100 |
48 |
$147.60 |